These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
267 related items for PubMed ID: 18765722
41. Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, Elkins KL, Puche AC, Michalek SM, Vogel SN. Infect Immun; 2007 Aug; 75(8):4127-37. PubMed ID: 17517865 [Abstract] [Full Text] [Related]
42. Phenotypic characterization of the Francisella tularensis ΔpdpC and ΔiglG mutants. Ozanic M, Marecic V, Lindgren M, Sjöstedt A, Santic M. Microbes Infect; 2016 Dec; 18(12):768-776. PubMed ID: 27477000 [Abstract] [Full Text] [Related]
44. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Chen W, Shen H, Webb A, KuoLee R, Conlan JW. Vaccine; 2003 Sep 08; 21(25-26):3690-700. PubMed ID: 12922099 [Abstract] [Full Text] [Related]
45. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R, Harris G, Conlan JW, Chen W. Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863 [Abstract] [Full Text] [Related]
46. Identifying Francisella tularensis genes required for growth in host cells. Brunton J, Steele S, Miller C, Lovullo E, Taft-Benz S, Kawula T. Infect Immun; 2015 Aug 10; 83(8):3015-25. PubMed ID: 25987704 [Abstract] [Full Text] [Related]
47. Identification of Francisella tularensis Himar1-based transposon mutants defective for replication in macrophages. Maier TM, Casey MS, Becker RH, Dorsey CW, Glass EM, Maltsev N, Zahrt TC, Frank DW. Infect Immun; 2007 Nov 10; 75(11):5376-89. PubMed ID: 17682043 [Abstract] [Full Text] [Related]
48. An attenuated strain of the facultative intracellular bacterium Francisella tularensis can escape the phagosome of monocytic cells. Golovliov I, Baranov V, Krocova Z, Kovarova H, Sjöstedt A. Infect Immun; 2003 Oct 10; 71(10):5940-50. PubMed ID: 14500514 [Abstract] [Full Text] [Related]
49. Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species. Moreau GB, Qin A, Mann BJ. J Bacteriol; 2018 Feb 15; 200(4):. PubMed ID: 29109188 [Abstract] [Full Text] [Related]
50. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL. Infect Immun; 2007 May 15; 75(5):2591-602. PubMed ID: 17296751 [Abstract] [Full Text] [Related]
51. A tolC mutant of Francisella tularensis is hypercytotoxic compared to the wild type and elicits increased proinflammatory responses from host cells. Platz GJ, Bublitz DC, Mena P, Benach JL, Furie MB, Thanassi DG. Infect Immun; 2010 Mar 15; 78(3):1022-31. PubMed ID: 20028804 [Abstract] [Full Text] [Related]
52. Ex vivo infection model for Francisella using human lung tissue. Köppen K, Fatykhova D, Holland G, Rauch J, Tappe D, Graff M, Rydzewski K, Hocke AC, Hippenstiel S, Heuner K. Front Cell Infect Microbiol; 2023 Mar 15; 13():1224356. PubMed ID: 37492528 [Abstract] [Full Text] [Related]
54. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. Barel M, Hovanessian AG, Meibom K, Briand JP, Dupuis M, Charbit A. BMC Microbiol; 2008 Sep 12; 8():145. PubMed ID: 18789156 [Abstract] [Full Text] [Related]
55. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge. Kijek TM, Mou S, Bachert BA, Kuehl KA, Williams JA, Daye SP, Worsham PL, Bozue JA. Microb Pathog; 2019 Dec 12; 137():103742. PubMed ID: 31513897 [Abstract] [Full Text] [Related]
56. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW. Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537 [Abstract] [Full Text] [Related]
57. The reduced genome of the Francisella tularensis live vaccine strain (LVS) encodes two iron acquisition systems essential for optimal growth and virulence. Pérez NM, Ramakrishnan G. PLoS One; 2014 Sep 26; 9(4):e93558. PubMed ID: 24695402 [Abstract] [Full Text] [Related]
58. Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Horzempa J, O'Dee DM, Shanks RM, Nau GJ. Infect Immun; 2010 Jun 26; 78(6):2607-19. PubMed ID: 20385757 [Abstract] [Full Text] [Related]
59. PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS. Cantlay S, Kaftanic C, Horzempa J. Front Cell Infect Microbiol; 2022 Jun 26; 12():979693. PubMed ID: 36237421 [Abstract] [Full Text] [Related]
60. Virulent and avirulent strains of Francisella tularensis prevent acidification and maturation of their phagosomes and escape into the cytoplasm in human macrophages. Clemens DL, Lee BY, Horwitz MA. Infect Immun; 2004 Jun 26; 72(6):3204-17. PubMed ID: 15155622 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]